Київський Науково-Дослiдний Iнститут Фаpмакологiї Та Токсикологiї
Киевский научно-исследовательский институт фармакологии и токсикологии
Українська Сільськогосподарська Академія
Украинская сельскохозяйственная академия
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Київський Науково-Дослiдний Iнститут Фаpмакологiї Та Токсикологiї, Киевский научно-исследовательский институт фармакологии и токсикологии, Українська Сільськогосподарська Академія, Украинская сельскохозяйственная академияfiledCriticalКиївський Науково-Дослiдний Iнститут Фаpмакологiї Та Токсикологiї
Priority to UA4420464ApriorityCriticalpatent/UA885A1/en
Publication of UA885A1publicationCriticalpatent/UA885A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The use of iodinemethylate-4-(N-benzene-carbamidopyridinium (Isamben) as the agent for treating the gastrointestinal diseases of the calves with diarrhea has been proposed. Isamben is non-steroid anti-inflammatory agent possessing anti-inflammatory, analgesic, and antipyretic activities. The invention relates to the physiologically active substances and may be used in veterinary for treating the gastrointestinal diseases of the newborn calves.
UA4420464A1988-02-151988-02-15Agent for treating gastrointestinal diseases of calves with diarrhea
UA885A1
(en)
PROCEDURES FOR THE TREATMENT AND PROPHYLAXY OF PNEUMOCYTIS CARINII PNEUMONI AND OTHER DISEASES AND COMPOUNDS AND FORMULATIONS FOR USE IN THE ABOVE METHODS.
A process for the preparation of compositions comprising a complete factor of development of therapeutic use of a complete solution for therapeutic or prophylactic treatment of a cataractic condition.
Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
Utilization of the "gel" pharmaceutical form containing n-(2.6-dichloro-m-tolil)-anthranilic acid (mechlophenamic acid) utilizable in therapy for topical usage